First Time Loading...

ADC Therapeutics SA
NYSE:ADCT

Watchlist Manager
ADC Therapeutics SA Logo
ADC Therapeutics SA
NYSE:ADCT
Watchlist
Price: 3.44 USD -6.27% Market Closed
Updated: Jul 21, 2024
Have any thoughts about
ADC Therapeutics SA?
Write Note

Wall Street
Price Targets

ADCT Price Targets Summary
ADC Therapeutics SA

Wall Street analysts forecast ADCT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ADCT is 10.2 USD with a low forecast of 8.08 USD and a high forecast of 13.65 USD.

Lowest
Price Target
8.08 USD
135% Upside
Average
Price Target
10.2 USD
197% Upside
Highest
Price Target
13.65 USD
297% Upside

ADCT Last Price Targets
ADC Therapeutics SA

The latest public price target was made on May 7, 2024 by Robert Burns from H.C. Wainwright , who expects ADCT stock to rise by 133% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Robert Burns
H.C. Wainwright
8 USD
Upside 133%
2 months ago
May 7, 2024
ADC Therapeutics (ADCT) PT Lowered to $8 at H.C. Wainwright
StreetInsider
Kelly Shi
Jefferies
13 USD
Upside 278%
4 months ago
Mar 13, 2024
ADC Therapeutics (ADCT) PT Lowered to $13 at Jefferies
StreetInsider
Robert Burns
H.C. Wainwright
Price Target 8 USD
Upside/Downside 133%
View Source
Kelly Shi
Jefferies
Price Target 13 USD
Upside/Downside 278%
View Source
ADC Therapeutics SA Competitors:
Price Targets
MAB
Mabion SA
5% Downside
BVXP
Bioventix PLC
44% Upside
XNCR
Xencor Inc
86% Upside
048530
iNtRON Biotechnology Inc
155% Upside
AURA
Aura Biosciences Inc
133% Upside
PANACEABIO
Panacea Biotec Ltd
48% Downside
AELIS
Aelis Farma SA
79% Upside
GNFT
Genfit SA
143% Upside

Revenue
Forecast

Revenue Estimate
ADC Therapeutics SA

For the last 5 years the compound annual growth rate for ADC Therapeutics SA's revenue is 129%. The projected CAGR for the next 3 years is 21%.

129%
Past Growth
21%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
ADC Therapeutics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
ADC Therapeutics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-21%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ADCT's stock price target?
Price Target
10.2 USD

According to Wall Street analysts, the average 1-year price target for ADCT is 10.2 USD with a low forecast of 8.08 USD and a high forecast of 13.65 USD.

What is ADC Therapeutics SA's Revenue forecast?
Projected CAGR
21%

For the last 5 years the compound annual growth rate for ADC Therapeutics SA's revenue is 129%. The projected CAGR for the next 3 years is 21%.